Pentwater Capital Management’s Avidity Biosciences RNAM Stock Holding History

Pentwater Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,026,500	Closed	-$435M	–	112
2025 Q4	$435M	Buy	+6,026,500	New	+$389M	2.29%	12
2020 Q3	–	Sell	-9,000	Closed	-$254K	–	239
2020 Q2	$254K	Buy	+9,000	New	+$259K	﹤0.01%	145

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Pentwater Capital Management's RNAM Position: Q1 2026 in Review

Pentwater Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 6,026,500 shares — an estimated $435M sold.

Pentwater Capital Management first reported a position in RNAM in Q2 2020 and held it in 2 quarters. The position peaked at $435M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Pentwater Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Pentwater Capital Management sold 6,026,500 Avidity Biosciences shares in Q1 2026, an estimated $435M.
Pentwater Capital Management first reported a position in Avidity Biosciences in Q2 2020 and held it in 2 quarters.
Pentwater Capital Management's Avidity Biosciences position peaked at $435M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Pentwater Capital Management's 13F filing for Q1 2026, filed 15 May 2026.